FDA Announces Proposed Collection of Information for Human Drug Compounding Outsourcing Facilities

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to fees for human drug compounding outsourcing facilities under the Federal Food, Drug, and Cosmetic Act, which has been submitted to the Office of Management and Budget (OMB) for review and clearance.